Cloud Concepts Hires Kyle Jones as Vice President of Sales & Marketing

Kyle Jones - Vice President of Sales & Marketing

Kyle Jones – Vice President of Sales & Marketing

The National Society of Leadership and Success inductee and graduating senior from Cal State San Marcos to join and lead the sales & marketing departments

Kyle is an inspiration and will lead by example!!”

— Shawn Jones

SAN DIEGO, CALIFORNIA, USA, May 31, 2021 /EINPresswire.com/ — Cloud Concepts Corp., a boutique master agency for Cloud Services, announced the hiring of Kyle Jones as its new Vice President of Sales & Marketing. As the newest member of the Cloud Concepts team, Jones will be responsible for creating fresh new “modern era” programs to continue the company’s focus on the best possible customer experience not only for their end users but for their agent community as well. He will also be working with key strategic supply partners to develop those program strategies into distinctive advantages for the agents, thus helping them close more business.

“We have kept our heads down and our foot on the gas! Growth and expansion are always exciting, and we are thrilled to welcome Kyle to our team! He will bring a fresh and smart kick to our business to elevate us even further!” said Brandi Jones, Cloud Concepts Vice President.

Kyle Jones has proven his capabilities in a multitude of ways, one of the most notable is he “Aced” his months long senior experience project. He and his teammates demonstrated their skills to a local San Diego business and developed an entirely new “go to market” strategy to revitalize their business. The company was so happy with their work, they are currently implementing their team’s designed marketing plan. But even more impressive, Jones has an impeccable track record, he will be graduating with a 4.0 GPA and he has been inducted to the nations largest honor society The National Society of Leadership and Marketing.

If you’d like to learn more about Kyle Jones and his contributions to our company, agents, and customers, please reach out to the Cloud Concepts new partner hotline 833-256-8399 (833-Cloud-99) or visit us online at https://cloud-concepts.com .

About Cloud Concepts
Cloud Concepts, Corp. is a boutique master agency specializing in cloud-related products: software-defined WAN (SD-WAN), disaster recover as a service (DRaaS), backup and storage, and unified communications as a service (UCaaS) and more. Agents and VAR partners choose Cloud Concepts for the “white glove customer experience” and specialized product portfolio. Cloud Concepts is fracturing the traditional “channel sales model” with their unique and new approach. This, coupled with the philosophy of doing good business (providing customers with the best business solutions at a fair price, providing Agents/VAR’s with the most comprehensive sales and operations support and providing all parties the best experience possible) makes Cloud Concepts the best choice. To learn more, please visit us at https://cloud-concepts.com/whatwedo

Shawn Jones
Cloud Concepts, Corp.
+1 714-351-2368
email us here


Source: EIN Presswire

ISSCA Hosts Regenerative Medicine Symposium in Istanbul, Turkey

A list of the speakers that were present at ISSCA’s Regenerative Medicine Symposium.

ISSCA has reopened its annual Regenerative Medicine Symposium for the Advancement of Cellular Therapies and Technology in Istanbul, Turkey.

MIAMI, FLORIDA , USA, May 31, 2021 /EINPresswire.com/ — After over a year of inactivity brought on by the COVID-19 pandemic, ISSCA has finally relaunched its annual Regenerative Medicine Symposium for the Advancement of Cellular Therapies and Technology in Istanbul, Turkey.

The world is finally beginning to once more open up to large gatherings of people. For the International Society for Stem Cell Applications, ISSCA, this has been a long time coming. The non-profit organization is renowned globally for bringing the benefits of regenerative medicine to countries around the world and fostering an international community of researchers through its conferences, the latest of which took place on May 27-28th at the Pullman Istanbul Hotel & Convention Center.

The symposium focused on bringing together doctors from all over the Middle East, as well as the world at large. During this event, physicians and researchers were given the opportunity to speak at panels to discuss the latest advancements in the rapidly growing field of regenerative medicine, chief among which were molecular biology, new models of treatment in surgical and cosmetic applications, and the latest technological advancements to hit the field. This includes a panel on Cellgenic Exosomes, which are the result of years of work towards finding a regenerative medicine product to cut down on strenuous operating room time. The proliferation of this information serves one purpose– the more effective treatment of patients suffering from degenerative disease around the world.

In addition to this, the conference also went over the legal landscape for the practice of regenerative medicine as it presents itself both in the United States (which is the model for many sovereign medical bodies) and abroad. Lectures were held throughout the day at this Symposium, which is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine, and provide the latest innovative discoveries and developments in all areas of stem cell research.

Istanbul, the economic, cultural, and historic center of Turkey, is the country’s most populous city. The luxurious Hotel Hyatt Regency, located near Istanbul’s Ataturk Airport, offers visitors the combination of comfort, culture, and convenience for exploring the ancient city. Symposium attendees will be able to discover sights such as the Blue Mosque and the Hagia Sophia.

ISSCA Vice President Benito Novas had this to say about the conference: “It really feels amazing to be back out– after so long with lockdowns, and travelling difficulties, we were wondering if we would have to wait even longer to host an event. It’s been far from ideal– even if the world locks down, research continues, and new breakthroughs come through in our field of regenerative medicine month after month. Our ISSCA Symposiums provide a great opportunity to spread this information out to the physicians who need it the most, and we plan to host as many as we can before the end of the year,”

To participate in one of ISSCA’s upcoming events, reserve your spot by registering today.

For more information, visit our website at https://www.issca.us/, email info@stemcellsgroup.com, or call +1305 560 5337.

About International Society for Stem Cells Applications

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

Benito Novas
GLOBAL STEM CELLS GROUP
+1 3055605337
email us here


Source: EIN Presswire

Non Profit Launches Business Pandemic Preparedness System

Press Conference June 1st, 2021, 11:00 am EST; the world needs pandemic preparedness, sustainability, and universal safe business practices.

We have to change the narrative. We need to take the politics out of our governance. We need to come together as a community if we are to be successful.”

— Steve Anderson

TORONTO, ONTARIO, CANADA, May 31, 2021 /EINPresswire.com/ — Over the past year, SmALL businesses have felt helpless, hopeless, unsupported, and confused. Witnessing the pain and challenges felt and faced by honest, hardworking people in our communities, it became very clear we MUST take action. This sparked the inception of the organization called Social Distance Management (SDM).

Edward Henry Company (EHCO) has made the decision to give away all licensing rights and intellectual property of SDM, which includes Social Distance Advisory (SDA), Social Distance Compliance (SDC) systems, and research to SmALL Business is Essential (SBE).

SDM believes that all businesses need universal compliance measures to operate safely during a pandemic and other unprecedented times. By having access to these practical systems, SBE will have the resources it needs to develop the support for all businesses. ALL businesses are essential, and business continuity is the focus. Any opportunities managed from these systems will help all businesses secure and implement adequate steps to stay open, thrive, and have their voices heard.

The Journey of Social Distance Management

In March of 2020, EHCO started SDM with a mission to stand by businesses. Two months later, on May 11, 2020, with extensive research, collaboration and data collection, they released their first version of universal compliance standards.

Under SDM, sub-resources, including SDA and SDC systems, were established to display universal compliance guidelines and assess the threat levels in specific areas to protect the population. The idea to start SDM came from the utmost care about people and businesses, not from a political approach. Universal health measures and the life of our economy are not two isolated conversations. It is ONE conversation.

To contribute to the information gathered, in July of 2020, a Research Internship was formed to discover and outline details on various businesses in Canada and the United States. The outcome of the research included details which contributed to SDC, such as further development of safety protocols, requirements for operation, compliance measures, capacity limits, and PPE requirements. SDM used the data collection to create additional tools, such as self-assessment audits that provide a checklist for what businesses need to stay compliant and operate safely.

Taking its cue from other systems such as ISO, Homeland Security, The World Health Organization, and research from John Hopkins University, SDM developed its Advisory system. This system was developed with the intent to assist businesses and communities in preparing for crises and mitigating restrictions. “There needs to be accountability to the decisions that are being made that affect our small businesses,” said President of EHCO, Edward Henry.

The Advisory system narrows in on the WHO’s Pandemic Phases and the Homeland Security system and uses five levels of risk and threat: low, moderate, substantial, severe, and critical. The colors associated include green, blue, yellow, orange, and red. Each phase clearly defines which business practices, products, and services are considered essential and non-essential and the types of businesses permitted to open during each phase. The Advisory system is currently in the process of implementing data from John Hopkins University, along with data collected by other reputable models.

Despite the aforementioned systems, resources, and extensive research to support our findings, ambiguous guidelines still remain. Therefore, businesses are left without genuine reasons as to why they cannot safely reopen and recover.

A Multi-faceted Problem Requires Innovative Solutions

Stand By SmALL Businesses and Our Communities

SmALL Business is Essential

After spending some time in the development phase, SDM ventured out and sought support from government officials and local politicians. After COUNTLESS meetings and constantly being redirected elsewhere, it was time to take drastic action. Edward Henry states, “Limited power is not an excuse for not doing the right thing.” This year has been about a lot of the wrong things, and in the beginning, SDM was seen as a profit-making opportunity, and taking advantage of a terrible situation. The lack of change cannot continue. Coming together as a collective unit is essential.

For sustainable change to happen, SDM’s resources need to be placed in the right hands. They need to be placed with an organization that isn’t narrow minded, but bilateral with its thinking so sectors, such as health and business can come together. SBE is a not-for-profit association that operates based on three core pillars: pandemic preparedness, sustainability, and safe business practices. SBE aims to collectively arm small businesses with the support, protection, and resources needed to operate safely while envisioning economic recovery and stability through business unity.

This pandemic is not just a small business problem; it’s a world problem. The government’s attempt to segregate businesses into non-essential and essential classifications created ambiguity. This ambiguity initiated the thought that, not some, but ALL businesses are essential. As EHCO releases all of its SDM systems, traffic, assessment, and auditing models to SBE, a new leadership position begins. SBE’s goals encompass the severity of the issue at hand, which is why there is no better person for the job than Steve Anderson. As a Social Entrepreneur, Olympic Gold Medal Coach, and Community Champion, Anderson takes over as President of the not-for-profit association SBE. Edward Henry states, “My choice to recruit Steve Anderson was because of his character, coaching background, competitive nature to overcome challenges, and his experience with a multi-faceted range of individuals.” Speaking to Anderson’s character, he doesn’t make excuses. Steve is a good man, and SBE needs his character to bring everyone together.

Along with Anderson’s motivating character, he is the first African American to coach an Olympic team in indoor or beach volleyball and the first to win an Olympic Gold Medal in either practice. Anderson is highly committed to being the driving force behind SBE to support ALL businesses. He, along with the efforts of SBE, will pave the way towards a better normal.

Our current actions reflect our future results. If we don’t continue putting in effort and showing our care for our businesses, we will continue losing pieces of our community and, in turn, our economy. Small businesses have experienced unfair measures and restrictions, putting them at risk for permanent closure. Continuous lockdowns are not a solution. “This current pandemic has cost over $20 trillion because we were not prepared,” said Edward Henry. The definition of insanity is to perform the same actions and expect different results. “We will do this over again if we don’t start changing the way we do things,” he added. The focus needs to be on Social Distance Compliance and universal protocols to preserve business continuity. If we want an improved normal, we need to stand by SmALL businesses and our communities. There is no better time than now to help businesses transition from lockdowns and longer than expected restrictions.

Register for Zoom Press Conference
https://zoom.us/meeting/register/tJEsde2rrjorHNwu-EbLrWmGCD9RyAUk9WEb

Location 10 Sunray Street, Suite 23
Whitby, Ontario L1N 9B5
Limited Space for TV Media only, call contacts below to confirm or email info@edwardhenry.com

Edward Henry
Edward Henry Company
+1 647-725-7575
email us here
Visit us on social media:
Facebook


Source: EIN Presswire

Freedom Founders Now Offering a Free Copy of Its Wealth Building Book for Dentists

An industry leader in dental retirement investing is giving dentists one of its most sought-after books at no cost.

ROCKWALL, TEXAS, UNITED STATES, May 31, 2021 /EINPresswire.com/ — Representatives with Freedom Founders announced today that it is now offering dentists the second edition of its book entitled, "From High Income To High Net Worth" for free.

"We're very excited about this," said Alex Lerma, Chief Marketing Officer and spokesperson for Freedom Founders. "This breakthrough book empowers dentists with alternative investment strategies to stop trading time for dollars and start creating cash flow, wealth, and freedom."

Lerma revealed that dentists can get their free copy from its website today. Lerma went on to describe From High Income To High Net Worth as the dentist's guide to freedom.

"It provides a guided tour to create your own personal wealth-building blueprint," Lerma stressed before adding, "This book reveals the right way to leverage and compound your equity and cash flow growth and hands you the knowledge and insight to start building wealth and cash flow outside of the practice."

But that's not all. Once dentists receive their free copy of From High Income To High Net Worth, they will, according to Lerma, discover how to control real estate investments without the ownership headaches and learn where they can find the best real estate investment opportunities without the risk of volatile markets.

As to how experts rate the book, John Groom, a CPA, highly recommends it.

"It’s the ultimate guide to building cash flow and net worth through real estate without ever meeting a tenant or fixing a toilet," Groom said.

Dr. Jim Rachor, a dentist in Michigan, also highly recommends anything Freedom Founders offers.

“I was in the stock market for most of my life,” Rachor recalled. “My father was a financial advisor, and we had money managers in New York. I am happy that my assets and money are out of that market and off the roller coaster that I used to ride. Especially when you get later in life because if you want to retire, it’s a roller coaster ride. You don’t have a lot of control. You can’t actually meet the people who are in the deal. Watching the panic now and the people who lost 30 percent or more of their assets in two weeks – that’s where I used to be. Not anymore. Now I sleep really well at night.”

Dr. Ben Jensen, a dentist from South Dakota, added, “Prior to joining Freedom Founders, we had substantial holdings in the stock market. We have redeployed our capital into alternative investments. We’re very pleased to be limited in our exposure to the stock market because this crash would have been devastating.”

For more information, please visit www.freedomfounders.com/our-story-retirement-for-dentists-orthodontists/ and https://www.freedomfounders.com/blog/.

###

About Freedom Founders

At Freedom Founders, our members invest in real, tangible assets that create sustainable cash flow – not Wall Street paper.

Contact Details:

519 E IH 30 # 246
Rockwall, TX 75087
United States

Alex Lerma
David Phelps International, LLC
+1 (972) 203-6960
email us here


Source: EIN Presswire

Innovative Systems nomeia Carlos Tomiato FinScan® Diretor de Vendas, Brasil

Innovative Systems Logo

BRAZIL, May 31, 2021 /EINPresswire.com/ — Innovative Systems, Inc., líder global no desenvolvimento e entrega de dados corporativos de alto desempenho e soluções de gerenciamento de risco, tem o prazer de anunciar que Carlos Tomiato ingressou na empresa como Diretor de Vendas do Brasil. Com sede em São Paulo, Carlos é responsável por conduzir a estratégia de crescimento de nossas soluções de combate a lavagem de dinheiro (AML) FinScan® da Innovative em toda a região e se concentrará no setor financeiro e em outros setores regulamentados.

Antes de ingressar na Innovative, Carlos foi sócio do grupo de advisory da KPMG Brasil, levando as ofertas de tecnologia com foco em risco, compliance e fraude da empresa aos clientes por meio de canais de parceiros locais e internacionais. Carlos também ocupou cargos de liderança sênior na Oracle, ATTPS Informática, Banco Espírito Santo (BES), Banco Pine, Senior Solutions, entre outros.

“Estou muito animado para representar a FinScan, líder global em soluções de Compliance/AML”, disse Tomiato. “A oferta da FinScan de dados da mais alta qualidade e tecnologia de correspondência é única e é o que permite aos clientes obter os resultados de triagem mais precisos do setor. O valor disso não pode ser subestimado – especialmente quando se trata de instituições financeiras onde os requisitos regulatórios e o risco de reputação são de vital importância no combate à lavagem de dinheiro, financiamento do terrorismo e outras atividades criminosas. Estou ansioso para trazer este produto excepcional para a industria financeira brasileira ”.

“Estamos muito satisfeitos por ter Carlos se juntando à equipe FinScan”, disse Ricardo Gonzalez, vice-presidente sênior para a América Latina. “Como parte do plano de crescimento estratégico de nossa empresa, continuamos a investir no mercado brasileiro, onde estamos presentes desde 1997. Carlos traz um histórico comprovado de percepções de mercado e sucesso de vendas que nos ajudará a fornecer a tecnologia líder da FinScan e aclamado customer service ao mercado brasileiro de Compliance/AML. ”

Sobre FinScan
FinScan é um provedor global de soluções avançadas de consultoria e Compliance AML / KYC, nas quais as principais organizações em todo o mundo confiam. Com base em décadas de experiência em qualidade de dados e tecnologias de correspondência de dados baseadas em IA, a precisão incomparável de rastreamento de risco e Compliance do FinScan ajuda a minimizar falsos positivos enquanto reduz o risco de perda de hits verdadeiros. As ofertas abrangentes do FinScan incluem sanções e triagem PEP, due diligence e triagem UBO, SWIFT / triagem e monitoramento de transações, ID Authentication e recursos de enriquecimento de dados. FinScan oferece opções de implantação flexíveis, incluindo On-premise, SaaS, híbrido, ou API´s ou WebServices para atender aos requisitos de privacidade de dados, eficiência ou segurança de nossos clientes.

CONTATO: Karin O'Sullivan Vice Presidente, Comunicações de Marketing (+1 412) 937-7678

kosullivan@innovativesystems.com

Karin OSullivan
Innovative Systems, Inc
+1 4129377678
email us here


Source: EIN Presswire

Global Humic Based Biostimulants Market Trends, Strategies, & Opportunities In The Humic Based Biostimulants Market 2021

Humic Based Biostimulants Market Report 2021: COVID-19 Growth And Change

Humic Based Biostimulants Global Market Report 2021: COVID-19 Growth And Change

The Business Research Company’s Humic Based Biostimulants Global Market Report 2021: COVID-19 Growth And Change

LONDON, GREATER LONDON, UK, May 31, 2021 /EINPresswire.com/ — According to the new market research report ‘Humic Based Biostimulants Humic Based Biostimulants Global Market Report 2021: COVID-19 Growth And Change’ published by The Business Research Company, the global humic-based biostimulants market is expected to grow from $496.46 million in 2020 to $538.61 million in 2021 at a compound annual growth rate (CAGR) of 8.49%. The growth is mainly due to the benefits associated with humic based biostimulants, rising need of sustainable agriculture and reduced in exploitation and wastage of conventional synthetic fertilizers. The humic-based biostimulants market is expected to reach $807.64 million in 2025 at a CAGR of 10.4%. Increase in the demand for the adoption of sustainable solutions in farming is driving the market growth of humic-based biostimulants.

Request For A Sample For The Global Humic Based Biostimulants Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4094&type=smp

The humic-based biostimulants market consists of sales humic-based biostimulants and related services by entities (organizations, sole traders and partnerships) that provide humic-based biostimulants. Biostimulants are substances applied to plants to enhance nutrition efficiency, abiotic stress tolerance and increase crop quality traits. Humic based biostimulants are commonly used in horticulture.

Trends In The Global Humic Based Biostimulants Market
Innovations in humic-based biosimulants such as chelation with different minerals are shaping the humic-based biostimulants market. Companies across the globe that are working on a wide variety of agricultural solutions with chelated additional minerals to enhance the nutraceutical nature of crops and plants. For instance, HuminTech, a German based humic substances producer, has launched a humic based biostimulant with iron chelation. The product can be used to prevent and correct iron deficiency symptoms in plants, along with increasing the resistance of plants to abiotic stress factors.

Global Humic Based Biostimulants Market Segments:
The global humic based biostimulants market is further segmented based on type and geography.
By Type: Fulvic Acid, Humic Acid, Potassium Humate
By Type Of Formulation: Liquid, Water-Soluble Granules, Water-Soluble Powders
By Mode of Application: Agriculture, Cereals, Fiber Crops, Fruits & Vegetables, Oilseeds
By End-User: Farmers, Related Industries, Research Institutes
By Geography: The global humic based biostimulants market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America is the largest region in the humic-based biosimulants market in 2020.

Read More On The Report For The Global Humic Based Biostimulants Market At:
https://www.thebusinessresearchcompany.com/report/humic-based-biostimulants-global-market-report

Humic Based Biostimulants Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides humic based biostimulants market overviews, analyzes and forecasts market size and growth for the global humic based biostimulants market, humic based biostimulants market share, humic based biostimulants market players, humic based biostimulants market segments and geographies, humic based biostimulants market’s leading competitors’ revenues, profiles and market shares. The humic based biostimulants market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Read Humic Based Biostimulants Global Market Report 2021 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

Humic Based Biostimulants Market Organizations Covered: Syngenta Group, Biolchim S.P.A, FMC Corporation, Haifa Group, UPL Limited, Bayer AG, Sikko Industries Ltd

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets. Here is a list of reports from The Business Research Company similar to the Humic Based Biostimulants Global Market Report 2021:

Biostimulants Global Market Report 2021: COVID 19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/biostimulants-market-global-report-2020-30-covid-19-growth-and-change

Powder Coatings Global Market Report 2021: COVID 19 Impact And Recovery To 2030
https://www.thebusinessresearchcompany.com/report/powder-coatings-global-market-report

Water Borne Coatings Global Market Report 2021: COVID 19 Impact And Recovery To 2030
https://www.thebusinessresearchcompany.com/report/water-borne-coatings-global-market-report

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Increasing Investments In Research Fuels Growth Of The Alpha Mannosidosis Market

Alpha Mannosidosis Market Report 2021: COVID-19 Growth And Change

Alpha Mannosidosis Global Market Report 2021: COVID-19 Growth And Change

The Business Research Company’s Alpha Mannosidosis Global Market Report 2021: COVID-19 Growth And Change

LONDON, GREATER LONDON, UK, May 31, 2021 /EINPresswire.com/ — Increasing investments in research is expected to contribute to the growth of the alpha mannosidosis market in the forecast period. Currently, in the alpha mannosidosis market, only one company has therapies for the rare genetic disease. However, several firms have products in the clinical stages, which will boost market demand in the forecast period. For instance, in 2020, the EU clinical trials database lists 39,219 clinical trials with a EudraCT protocol, 6,426 of which are clinical trials involving subjects under the age of 18. Therefore, the increasing investment in research fuels the growth of the alpha mannosidosis market.

The alpha mannosidosis market consists of sales of therapies for alpha mannosidosis (organizations, sole traders and partnerships) that provides treatment for alpha mannosidosis, which is a lysosomal storage disorder. Lysosomes are particles bound in membranes within cells that function as the primary digestive units. Alpha-mannosidosis is a rare genetic inherited condition that affects the organs and tissues of the person suffering from the disease. The treatment therapy focuses on detecting and preventing polysaccharide accumulations within mutant cells, which can cause harm to tissue, organs, and eventually death. Polysaccharides are defined as larger molecules composed of several linked sugar molecules.

Read More On The Global Alpha Mannosidosis Market Report:
https://www.thebusinessresearchcompany.com/report/alpha-mannosidosis-global-market-report

The global alpha mannosidosis market size is expected to grow from $7.50 million in 2020 to $8.89 million in 2021 at a compound annual growth rate (CAGR) of 18.6%. The growth is mainly due to increasing prevalence of alpha mannosidosis, use of orphan drugs, fee reductions and tax credits, increasing investment in the rare disease treatment and advancements in treatment drugs. The alpha mannosidosis market is expected to reach $17.91 million in 2025 at a CAGR of 19.1%.

North America was the largest region in the alpha mannosidosis market in 2020. Asia Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the alpha mannosidosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Major players in the alpha mannosidosis market are Chiesi Farmaceutici S.p.A., Nuo Therapeutics, and Zymenex.

The global alpha mannosidosis market research report is segmented –
1) By Therapy Type: Bone Marrow Transplant (BMT), Enzyme Replacement Therapy (ERT), Peripheral Blood Stem Cell Transplantation (PBSCT), Gene Therapy
2) By Indication: Type I, Type II, Type III
3) By End-User: Hospitals, Specialty Clinics.

Alpha Mannosidosis Global Market Report 2021: COVID-19 Growth And Change is one of a series of new reports from The Business Research Company that provides alpha mannosidosis global market overview, forecast alpha mannosidosis global market size and growth for the whole market, alpha mannosidosis global market segments, and geographies, alpha mannosidosis global market trends, alpha mannosidosis global market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Alpha Mannosidosis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4093&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Transplant Diagnostics Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/transplant-diagnostics-global-market-report

Oral Biologics And Biosimilars Market – By Therapeutic Mechanism (Tumor Necrosis Factor-Alpha Inhibitors, Lymphocyte Modulators, Interleukin Inhibitors, GPCR (insulin, growth hormone, parathyroid hormone) Modulators, Immunostimulants, Others), By Disease (Diabetes, Arthritis & Chron`s Disease, Cancer, Infectious Diseases, Other Autoimmune Diseases, Others Diseases), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilars-market

Cell and Gene Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-global-market-report-2020-30-covid-19-growth-and-change

Pharmaceuticals Market – By Type (Pharmaceutical Drugs, Biologics), By Type Of Pharmaceutical Drugs (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs), By Type Of Biologics Drugs (Monoclonal Antibodies (MAbs), Therapeutic Proteins, Vaccines), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Interested to know more about The Business Research Company?

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

The Blood Group Typing Industry Grew With Increasing Number Of Blood Donations And Transfusions

Blood Group Typing Market Report 2021: COVID-19 Growth And Change

Blood Group Typing Global Market Report 2021: COVID-19 Growth And Change

The Business Research Company’s Blood Group Typing Global Market Report 2021: COVID-19 Growth And Change

LONDON, GREATER LONDON, UK, May 31, 2021 /EINPresswire.com/ — Increasing number of blood donations and transfusions drove the blood group typing market during the historic period. Different non-profit organizations, government organizations and other agencies are emphasizing on the importance of blood donations and transfusions and spreading awareness through various campaigns. Increase in blood donations increased the demand for blood group typing so that the donor can know what type of blood they have. For instance, according to WHO, blood donations have increased from 2013 to 2018 with 7.8 million blood donations from voluntary unpaid donors being reported from 2013 to 2018. The increase in number of blood donations and transfusions, thereby contributed to growth of the blood typing market.

The blood group typing market consists of sale of blood group typing products and related services by entities (organizations, sole traders and partnerships) that provide blood group type details that are derived from certain tests. Blood group typing is a method that tells the type of blood a person has and it is done so that a person can safely donate blood or receive a blood transfusion.

Read More On The Global Blood Group Typing Market Report:
https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report

The global blood group typing market is expected to grow from $2.08 billion in 2020 to $2.34 billion in 2021 at a compound annual growth rate (CAGR) of 12.37%. The growth is mainly due to the rise in blood transfusions, crossmatch testing and prenatal testing, and technology advancements in blood testing reagents and instruments. The blood group typing market is expected to reach $3.59 billion in 2025 at a CAGR of 11.28%.

North America was the largest region in the blood group typing market in 2020. Asia Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the blood group typing global market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Major players in the blood group typing industry are Grifols, Bio-Rad Laboratories, Immucor Inc., Ortho Clinical Diagnostics, Quotient, BAG Health Care GmbH, AXO Science, Agena Bioscience, Merck KGaA, Beckman Coulter Inc, Sucuri Inc, Rapid Labs, AXO Science, Day Medical SA, and Novacyt Group.

The global blood group typing market is segmented by test type into antibody screening, cross-matching tests, ABO tests, antigen typing, HLA typing, by product into instruments, reagents and kits, by techniques into serology tests, molecular tests, and by end user into hospital based laboratories, independent laboratories and blood banks.

Blood Group Typing Global Market Report 2021: COVID-19 Growth And Change is one of a series of new reports from The Business Research Company that provides blood group typing global market overview, forecast blood group typing market size and growth for the whole market, blood group typing global market segments, and geographies, blood group typing market trends, blood group typing global market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Blood Group Typing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4092&type=smp

Here Is A List Of Similar Reports By The Business Research Company:
Patient Blood Management Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/patient-blood-management-market-global-report-2020-30-covid-19-growth-and-change

Blood Transfusion Diagnostics Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Blood Glucose Test Strips Market – By Technology (Glucose Oxidase And Glucose Dehydrogenase), By Type (Thick Film Electrochemical Films, Thin Film Electrochemical Films And Optical Strips), And By Region, Opportunities And Strategies – Global Forecast To 2023
https://www.thebusinessresearchcompany.com/report/blood-glucose-test-strips-market

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn


Source: EIN Presswire

Deep Pharma Intelligence Releases Analytical Report "Cell Therapies In Healthcare Landscape Overview 2021"

“Cell Therapies In Healthcare Landscape Overview 2021 (Stem Cells and CAR-Ts)”

“Cell Therapies In Healthcare Landscape Overview 2021 (Stem Cells and CAR-Ts)”

Deep Pharma Intelligence (DPI) is a leading UK-based strategic and investment intelligence agency focused on the emerging markets in the Pharmaceutical, Biotech, MedTech and Healthcare Tech industries”

— Deep Pharma Intelligence

LONDON, UNITED KINGDOM, May 31, 2021 /EINPresswire.com/ — Deep Pharma Intelligence released a special 115-page analytical report Cell Therapies In Healthcare Landscape Overview 2021 (Stem Cells and CAR-Ts), which is the first comprehensive and systematic overview of cell therapies landscape by the company. This report is specifically focused on Stem Cell therapies and Chimeric Antigen Receptor T-cell (CAR-T) therapies, and it is the first edition in a series of reports covering the landscape of cell therapies and related technologies and products.

The main aim of this report is to profile an ecosystem of biotech companies and technology developers, applying advanced biology techniques, experimentation tools, and advanced data analytics technologies for creating state-of-the-art stem cell-based products and therapies, and for creating robust clinically efficient and personalized CAR-T therapies — two exciting and rapidly evolving areas of modern biotech.

Link to the report "Cell Therapies In Healthcare Landscape Overview 2021 (Stem Cells and CAR-Ts)" – www.deep-pharma.tech/cell-therapies.

This report highlights 400 biotech companies and vendors, 200 biotech investors, and 15 pharma corporations active in the areas of stem cells research and CAR-T therapies, as well as selected R&D collaborations, funding rounds, research trends, industry trends, selected case studies, and other actionable insights about the industry.

With more than 100.000 research publications and above 1000 clinical trials taking place globally, the area of cell therapies research (stem cell and CAR-T) is steadily expanding in terms of new knowledge and understanding of fundamental biological processes associated with production and application of stem cells, CAR-T technologies, and other cell therapies in general. The area is characterized by a steady flow of scientific breakthroughs with high translational potential, which opens up a landscape of opportunities for prospective investors.

However, notwithstanding of substantial amount of clinical data showing relative safety and efficacy of cell therapies, related to stem cells and CAR-T, the overall presence of commercially available medical products and services is still rather limited, which is reflective of the fact that the market is in early days of development — with substantial growth potential overall.

Up to now, only 5 CAR-T therapies has been approved by FDA, including Abecma by Bluebird Bio and Bristol Myers Squibb, Tecartus™ by Kite Pharma, and others, as well as 19 Stem Cell products — all being blood-forming stem cells (also known as hematopoietic progenitor cells) that are derived from umbilical cord blood. These products are approved for use in patients with disorders that affect the production of blood.

The market of cell therapies is currently a growing opportunity for the private and institutional investors, and we expect the acceleration of funding inflow into the segments of stem cells and CAR-T technologies in the upcoming 2-5 years. Especially interesting opportunities emerge when companies develop specialized R&D platforms, capable of producing results with a wide variety of products and therapeutics areas.

About Deep Pharma Intelligence
Deep Pharma Intelligence is a joint venture of Deep Knowledge Analytics Pharma Division and BPT Analytics (BiopharmaTrend) producing powerful data mining and visualization systems, interactive analytics dashboards and industry reports offering deep technical insights, business intelligence, competitive analysis, industry benchmarking and strategic guidance in high growth and large opportunity areas of the pharma sector, including AI in drug discovery, emerging therapeutic targets and drug modalities, new therapies and technologies, promising startups, and more.

About Deep Knowledge Analytics
Deep Knowledge Analytics is a DeepTech focused agency producing advanced analytics on DeepTech and frontier-technology industries using sophisticated multi-dimensional frameworks and algorithmic methods that combine hundreds of specially-designed and specifically-weighted metrics and parameters to deliver insightful market intelligence, pragmatic forecasting and tangible industry benchmarking.

About BPT Analytics (BiopharmaTrend)
BiopharmaTrend is a leading provider of analytics, market intelligence, articles, opinions, commentaries, and interviews on the pharmaceutical and healthcare industries. They are also currently developing an analytics platform that maps companies, competitors, key people, deals, venture rounds, news, trends, research articles, patents and other important data elements into industry knowledge graphs. The company was created to serve as a research engine for marketers, investors, business developers, innovation scouts, and all types of consultants looking for strategic and tactical insights into the pharma industry and healthcare.

About Deep Knowledge Group
Deep Knowledge Group is an international consortium of commercial and non-profit organizations focused on the synergetic convergence of DeepTech and Frontier Technologies (AI, Longevity, MedTech, FinTech, GovTech), applying progressive data-driven Invest-Tech solutions with a long-term strategic focus on AI in Healthcare, Longevity and Precision Health, and aiming to achieve positive impact through the support of progressive technologies for the benefit of humanity via scientific research, investment, entrepreneurship, analytics and philanthropy.

For press and media inquiries, please contact: info@deep-pharma.tech

Dr. Andrii Buvailo
Deep Pharma Intelligence
info@deep-pharma.tech


Source: EIN Presswire

Fovere Cremation Urns, Offers a Reassuring Celebration of Life for our Love Ones

Fovere Logo

Fovere Logo

Flowers displayed in the Memorial Vase Urn

Flowers displayed in the Memorial Vase Urn

Candle Urn

Candle Urn

Introducing the unique 'Memorial Vase Urn' by Fovere, providing an alternative and attractive choice, designed for display at home.

After struggling to find a cremation urn to be displayed at home without making guests feel uncomfortable. We set out to find a commemorative urn that was designed for display within the home.”

— Kim Clay, co-founder of Fovere

HILLARYS, WESTERN AUSTRALIA, AUSTRALIA, May 31, 2021 /EINPresswire.com/ — Fovere has stepped outside the box to create a cremation urn unlike any other, one that focuses on celebrating a loved one's life and preserving their legacy.

Designed to be positioned at the heart of your home, this memorial urn keeps your loved one close to you.

The Memorial Vase Urn is a full-size cremation urn designed to resemble a lovely flower vase in both appearance and function. This concept is entirely unique and unlike any other cremation urn. Combining the precious cremation urn, used to protect and memorialise those closest to us, with the profound symbolism of flowers, used in remembrance and as a demonstration of our love, creates a synergistic tribute honouring and memorializing those we have lost.

The main urn is fully sealed and separate from the flower container, with a secure screw-in base, allowing easy access to the ashes compartment. A neatly concealed standalone vase insert slides out from the top, making this vase extremely practical and simple to use.
This feature enables you to arrange flowers, change the water, and clean the cremation urn without having to move the entire urn. Individually hand cast from aluminum, you won't have to worry about these memorial urns getting knocked over while on display, the ashes will remain safely protected within the ash compartment.

The Memorial Vase Urn's design allows for display with or without flowers. Adding fresh or faux flowers to the vase provides a stunning memorial. Valentine's Day roses, Mother's Day tulips, or Gerbera daisies simply because you're thinking of them and the love you shared, displaying the flowers they loved. Take comfort by creating the ideal memorial to honor their memory and celebrate their life.

Along with the unique Memorial Vase Urn, Fovere also provides a Candle Cremation Urn, which allows you to light a candle in honour of your loved one as you reflect on the happy moments shared, take a moment of peaceful reflection, meditation, or say a silent prayer.

These urns are offered in two sizes: a large full-size urn and a small keepsake urn.

This is another decorative style of urn that provides a more elegant alternative to traditional urns, ensuring that your loved one rests in comfort, near you, at home.

With an increase in the frequency where an individuals ashes are divided amongst family members, the 'small keepsake urn' is Foveres' most popular urn, frequently purchased in sets of three or four.

Fovere translates as "To Cherish" in Latin, which is mirrored in our brand philosophy and product offering. We realise how tough it is to say goodbye, not only immediately following someone's death, but for the days, weeks, months, and even years thereafter. Our urns provide a more personal approach to honor those you love and miss, allowing you to keep them at the forefront of your heart and home for eternity.

The Memorial Vase Urn and Candle Urn collections are currently available to order.

Find out more at https://fovere.net

Kim Clay
Fovere
support@fovere.net


Source: EIN Presswire